Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: EC:1.10.3.1 (
tyrosinase
)
9,065
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
Rabbit anti-
tyrosinase
antibodies were used to study the abundance, processing, and degradation of
tyrosinase
in murine (Cloudman) melanoma cells. The polyclonal antibodies precipitated low-molecular-weight (68,000 and 70,000) and high-molecular-weight (78,000 and 80,000) tyrosinases that had a precursor-product relationship. Cells with high basal
tyrosinase
activity had high levels of newly synthesized
tyrosinase
. Cells with low
tyrosinase
activity synthesized less
tyrosinase
and degraded the enzyme at a faster rate than cells with high
tyrosinase
activity. Melanotropin (melanocyte stimulating hormone), dibutyryl cyclic adenosine monophosphate, and isobutylmethylxanthine caused an increase in the abundance of newly synthesized
tyrosinase
that was directly proportional to the increase in enzyme activity. This enzyme was not a
phosphoprotein
. Other changes in the culture conditions that increased the level of
tyrosinase
activity increased the abundance of newly synthesized enzyme. It is thus concluded that the level of
tyrosinase
activity in Cloudman melanoma cells is a direct reflection of the abundance of enzyme protein.
...
PMID:Tyrosinase activity and abundance in Cloudman melanoma cells. 620 Nov 40
Melanogenesis is a cascade of events significantly controlled by regulatory genes which are associated with the melanosomal membrane. This report introduces our current research efforts dealing with (a) the gene and protein expressions of
tyrosinase
and Lamp (lysosome-associated membrane protein) families by human melanoma cells after repeated exposures to UV light, (b) the coordinated alterations in the expression of the Lamp family gene and its encoding product after transfection of two genes of the
tyrosinase
family in human melanoma cells and (c) cloning and sequencing of a Ca(2+)-binding
phosphoprotein
, calnexin, which could be a candidate as a chaperone for sorting and maturation of
tyrosinase
and Lamp family glycoproteins in melanogenesis cascade. Our UV exposure study, as well as gene transfection and antisense hybridization experiments, has clearly indicated a marked and coordinated interaction of the Lamp-1 gene with the
tyrosinase
and TRP-1 genes in this process. We propose that melanogenesis is controlled at least by two major gene family products, i.e., (a) the
tyrosinase
family of
tyrosinase
, TRP-1 and TRP-2, and the Lamp family of Lamp-1, Lamp-2 and Lamp-3. These two gene families probably derived from primordial melanogenesis-associated genes which are common or closely related to each other.
...
PMID:Molecular control of melanogenesis in malignant melanoma: functional assessment of tyrosinase and lamp gene families by UV exposure and gene co-transfection, and cloning of a cDNA encoding calnexin, a possible melanogenesis "chaperone". 753 26
The polyether toxin, bistratene A, induced morphological and functional differentiation of a human melanoma cell line (MM96E). The cells became blocked at the G2/M transition and elaborated a number of processes. Tyrosinase activity and melanin content were substantially increased. Northern blot analysis showed up-regulation of mRNA for several genes known to be involved in melanin biosynthesis (pmel17, pmel34, and
tyrosinase
related proteins, TRP-1 and TRP-2). Bistratene A induced the phosphorylation of several proteins as assessed by 2D gel electrophoresis and one of these was identified as stathmin (oncoprotein 18), a cell-cycle regulated
phosphoprotein
. Bistratene A specifically induced the translocation of protein kinase Cdelta (PKCdelta) from a soluble to a particulate fraction without affecting other isoforms. These results implicate a role for protein kinase Cdelta in the induction of differentiation of this human melanoma cell line.
...
PMID:Stimulation of melanogenesis in a human melanoma cell line by bistratene A. 963 6